Gestational diabetes/diabetes mellitus prevention Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Eligible women with normal fasting plasma glucose values between 6 and 12 weeks after delivery were randomly assigned to receive:
1. Standard treatment: 1 hour education session and follow up by famil
Sponsors
St Carlos Hospital (Hospital Clínico San Carlos) (Spain)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women diagnosed with gestational diabetes mellitus between 24 and 28 weeks of gestation by Couston and Carpenter criteria between January 2006 and December 2007 2. Normal fasting glucose values (less than 100 mg/dl) between 8 - 12 weeks after delivery
Exclusion criteria
Exclusion criteria: 1. Fasting glucose level greater than 100 mg/dl between 8 - 12 weeks after delivery 2. New gestation during 3-years follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimation of the conversion rate to abnormal glucose tolerance (type 2 diabetes mellitus, IFG and IGT) of women with prior gestational diabetes mellitus (GDM) and normal fasting glucose values after delivery, measured yearly. | — |
Secondary
| Measure | Time frame |
|---|---|
| Estimation of the changes in: 1. HbA1c 2. Insulin 3. Homestatic model assessment (HOMA) 4. Total (high density lipoprotein [HDL] and low density lipoprotein [LDL]) cholesterol 5. Triglycerides 6. Apolipoprotein B 7. Cytokines 8. Body weight 9. Waist circumference 10. Blood pressure 11. Adherence to changes in lifestyle All outcomes are measured yearly. | — |
Countries
Spain
Outcome results
None listed